These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7356417)

  • 1. Dystonic foot response of Parkinsonism.
    Nausieda PA; Weiner WJ; Klawans HL
    Arch Neurol; 1980 Mar; 37(3):132-6. PubMed ID: 7356417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystonia in untreated parkinsonism.
    LeWitt PA; Burns RS; Newman RP
    Clin Neuropharmacol; 1986; 9(3):293-7. PubMed ID: 3719574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease.
    Pouclet H; Derkinderen P; Lebouvier T
    Clin Neurol Neurosurg; 2013 Feb; 115(2):235-6. PubMed ID: 22743235
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of foot dystonia in parkinsonism.
    Poewe WH; Lees AJ
    Clin Neuropharmacol; 1987; 10(1):47-56. PubMed ID: 3545460
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxial response to dopaminergic agents in parkinsonism.
    Wiener WJ; Kramer J; Nausieda PA; Klawans HL
    Arch Neurol; 1978 Jul; 35(7):453-5. PubMed ID: 666596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa-associated hemifacial dystonia.
    Mark MH; Sage JI
    Mov Disord; 1991; 6(4):383. PubMed ID: 1758464
    [No Abstract]   [Full Text] [Related]  

  • 7. End-of-dose dystonia in Parkinson's disease.
    Bravi D; Mouradian MM; Roberts JW; Davis TL; Chase TN
    Neurology; 1993 Oct; 43(10):2130-1. PubMed ID: 8413978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Klawans HL; Paleologos N
    Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease: new treatments.
    Stewart RM
    Compr Ther; 1981 Apr; 7(4):38-44. PubMed ID: 7237986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutics of disordered movement.
    Sears ES
    Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients who fail to respond to levodopa therapy.
    Duvoisin RC
    Clin Neuropharmacol; 1982; 5 Suppl 1():S13-8. PubMed ID: 7116342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of parkinsonism.
    Calne DB; Teychenne PF; Pfeiffer RF
    Adv Exp Med Biol; 1977; 90():49-61. PubMed ID: 930750
    [No Abstract]   [Full Text] [Related]  

  • 14. Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
    Tarsy D; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1975 Apr; 38(4):331-5. PubMed ID: 1095689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [L-dopa therapy of parkinson syndrome].
    Kapfhammer HP; Kuss HJ; Rüther E
    Nervenarzt; 1985 Feb; 56(2):57-68. PubMed ID: 3920542
    [No Abstract]   [Full Text] [Related]  

  • 16. Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease.
    Weiner WJ; Nausieda PA
    Arch Neurol; 1982 Jul; 39(7):451-2. PubMed ID: 7103786
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholinergic and dopaminergic mechanisms in Parkinson's disease after long term levodopa administration.
    Yahr MD; Clough CG; Bergmann KJ
    Lancet; 1982 Sep; 2(8300):709-10. PubMed ID: 6126641
    [No Abstract]   [Full Text] [Related]  

  • 18. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
    [No Abstract]   [Full Text] [Related]  

  • 19. Parkinsonism following dystonia in three patients.
    Katchen M; Duvoisin RC
    Mov Disord; 1986; 1(2):151-7. PubMed ID: 3504239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carbidopa-levodopa, growth hormone and parkinsonism].
    Marti-Masso JF; Carrera N; Martínez-Lage JM
    Rev Clin Esp; 1976 Jun; 141(6):525-32. PubMed ID: 968087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.